Cargando…

Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling

Congenital heart disease can lead to severe right ventricular heart failure (RVHF). We have shown that aggregated c‐kit(+) progenitor cells (CPCs) can improve RVHF repair, likely due to exosome‐mediated effects. Here, we demonstrate that miRNA content from monolayer (2D) and aggregated (3D) CPC exos...

Descripción completa

Detalles Bibliográficos
Autores principales: Trac, David, Hoffman, Jessica R., Bheri, Sruti, Maxwell, Joshua T., Platt, Manu O., Davis, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811701/
https://www.ncbi.nlm.nih.gov/pubmed/31385648
http://dx.doi.org/10.1002/sctm.19-0059
_version_ 1783462522450345984
author Trac, David
Hoffman, Jessica R.
Bheri, Sruti
Maxwell, Joshua T.
Platt, Manu O.
Davis, Michael E.
author_facet Trac, David
Hoffman, Jessica R.
Bheri, Sruti
Maxwell, Joshua T.
Platt, Manu O.
Davis, Michael E.
author_sort Trac, David
collection PubMed
description Congenital heart disease can lead to severe right ventricular heart failure (RVHF). We have shown that aggregated c‐kit(+) progenitor cells (CPCs) can improve RVHF repair, likely due to exosome‐mediated effects. Here, we demonstrate that miRNA content from monolayer (2D) and aggregated (3D) CPC exosomes can be related to in vitro angiogenesis and antifibrosis responses using partial least squares regression (PLSR). PLSR reduced the dimensionality of the data set to the top 40 miRNAs with the highest weighted coefficients for the in vitro biological responses. Target pathway analysis of these top 40 miRNAs demonstrated significant fit to cardiac angiogenesis and fibrosis pathways. Although the model was trained on in vitro data, we demonstrate that the model can predict angiogenesis and fibrosis responses to exosome treatment in vivo with a strong correlation with published in vivo responses. These studies demonstrate that PLSR modeling of exosome miRNA content has the potential to inform preclinical trials and predict new promising CPC therapies. stem cells translational medicine 2019;8:1212–1221
format Online
Article
Text
id pubmed-6811701
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68117012019-10-30 Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling Trac, David Hoffman, Jessica R. Bheri, Sruti Maxwell, Joshua T. Platt, Manu O. Davis, Michael E. Stem Cells Transl Med Tissue Engineering and Regenerative Medicine Congenital heart disease can lead to severe right ventricular heart failure (RVHF). We have shown that aggregated c‐kit(+) progenitor cells (CPCs) can improve RVHF repair, likely due to exosome‐mediated effects. Here, we demonstrate that miRNA content from monolayer (2D) and aggregated (3D) CPC exosomes can be related to in vitro angiogenesis and antifibrosis responses using partial least squares regression (PLSR). PLSR reduced the dimensionality of the data set to the top 40 miRNAs with the highest weighted coefficients for the in vitro biological responses. Target pathway analysis of these top 40 miRNAs demonstrated significant fit to cardiac angiogenesis and fibrosis pathways. Although the model was trained on in vitro data, we demonstrate that the model can predict angiogenesis and fibrosis responses to exosome treatment in vivo with a strong correlation with published in vivo responses. These studies demonstrate that PLSR modeling of exosome miRNA content has the potential to inform preclinical trials and predict new promising CPC therapies. stem cells translational medicine 2019;8:1212–1221 John Wiley & Sons, Inc. 2019-08-06 /pmc/articles/PMC6811701/ /pubmed/31385648 http://dx.doi.org/10.1002/sctm.19-0059 Text en © 2019 The Authors. stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Tissue Engineering and Regenerative Medicine
Trac, David
Hoffman, Jessica R.
Bheri, Sruti
Maxwell, Joshua T.
Platt, Manu O.
Davis, Michael E.
Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling
title Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling
title_full Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling
title_fullStr Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling
title_full_unstemmed Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling
title_short Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling
title_sort predicting functional responses of progenitor cell exosome potential with computational modeling
topic Tissue Engineering and Regenerative Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811701/
https://www.ncbi.nlm.nih.gov/pubmed/31385648
http://dx.doi.org/10.1002/sctm.19-0059
work_keys_str_mv AT tracdavid predictingfunctionalresponsesofprogenitorcellexosomepotentialwithcomputationalmodeling
AT hoffmanjessicar predictingfunctionalresponsesofprogenitorcellexosomepotentialwithcomputationalmodeling
AT bherisruti predictingfunctionalresponsesofprogenitorcellexosomepotentialwithcomputationalmodeling
AT maxwelljoshuat predictingfunctionalresponsesofprogenitorcellexosomepotentialwithcomputationalmodeling
AT plattmanuo predictingfunctionalresponsesofprogenitorcellexosomepotentialwithcomputationalmodeling
AT davismichaele predictingfunctionalresponsesofprogenitorcellexosomepotentialwithcomputationalmodeling